TREOSULFAN

TREOSULFAN was reported 2760 times

TREOSULFAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PSTPIP1-ASSOCIATED MYELOID-RELATED PROTEINAEMIA INFLAMMATORY SYNDROME 4 0.6667
1 LUNG DISEASE INFECTIVE EXACERBATION 16 0.5926
2 BACILLE CALMETTE-GUERIN SCAR REACTIVATION 7 0.5833
3 ADENOVIRUS REACTIVATION 53 0.3681
4 SPLENIC CANDIDIASIS 6 0.2609
5 HEPATIC IRON OVERLOAD 6 0.2609
6 TRANSFUSION MICROCHIMERISM 2 0.2500
7 JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA 10 0.1961
8 ACUTE GRAFT VERSUS HOST DISEASE ORAL 6 0.1935
9 PERINEAL ULCERATION 27 0.1929
10 HERPES SIMPLEX PNEUMONIA 24 0.1890
11 VACCINATION SITE INFLAMMATION 9 0.1579
12 CHIMERISM 14 0.1573
13 SAPOVIRUS INFECTION 5 0.1562
14 AUTOIMMUNE PANCYTOPENIA 14 0.1538
15 HUMAN HERPESVIRUS 6 VIRAEMIA 6 0.1500
16 MICROCOCCAL SEPSIS 3 0.1500
17 PNEUMORETROPERITONEUM 9 0.1200
18 PERIORBITAL INFECTION 9 0.1111
19 VIRAL OESOPHAGITIS 2 0.1053
20 BK POLYOMAVIRUS TEST POSITIVE 10 0.1042
21 CARTILAGE HYPERTROPHY 2 0.1000
22 UNDIFFERENTIATED SARCOMA 5 0.0980
23 CENTRAL NERVOUS SYSTEM VIRAL INFECTION 14 0.0979
24 URINARY TRACT INFECTION VIRAL 10 0.0943
25 IDIOPATHIC PNEUMONIA SYNDROME 28 0.0940
26 LEUKAPHERESIS 2 0.0909
27 HUMAN HERPESVIRUS 7 INFECTION 7 0.0886
28 MUCOEPIDERMOID CARCINOMA OF SALIVARY GLAND 5 0.0847
29 KAPOSI SARCOMA INFLAMMATORY CYTOKINE SYNDROME 5 0.0847
30 ADENOVIRUS INFECTION 240 0.0827
31 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 213 0.0770
32 CHRONIC LYMPHOCYTIC INFLAMMATION WITH PONTINE PERIVASCULAR ENHANCEMENT RESPONSIVE TO STEROIDS 2 0.0769
33 ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY ABNORMAL 1 0.0769
34 GASTROENTERITIS ADENOVIRUS 12 0.0764
35 QUADRANTANOPIA 10 0.0763
36 GRAFT VERSUS HOST DISEASE IN SKIN 168 0.0762
37 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 101 0.0715
38 ACHROMOBACTER INFECTION 8 0.0667
39 CYTOMEGALOVIRUS INFECTION REACTIVATION 293 0.0663
40 ENTEROCOLITIS VIRAL 20 0.0658
41 HUMAN HERPESVIRUS 6 INFECTION 124 0.0655
42 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 134 0.0629
43 GASTROENTERITIS ASTROVIRAL 5 0.0625
44 VIRAL HAEMORRHAGIC CYSTITIS 43 0.0604
45 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 21 0.0598
46 PARAINFLUENZA VIRUS INFECTION 6 0.0583
47 OTITIS MEDIA BACTERIAL 2 0.0571
48 HERPES SIMPLEX VIRAEMIA 7 0.0560
49 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 26 0.0557
50 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS 5 0.0538
51 SERUM AMYLOID A PROTEIN INCREASED 8 0.0516
52 STENOTROPHOMONAS SEPSIS 6 0.0496
53 FUNGUS SEROLOGY TEST POSITIVE 2 0.0476
54 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 43 0.0464
55 AUTOIMMUNE NEUTROPENIA 13 0.0450
56 PARVOVIRUS B19 INFECTION 40 0.0447
57 MENINGITIS ENTEROVIRAL 4 0.0430
58 PROTOTHECOSIS 4 0.0426
59 ENGRAFTMENT SYNDROME 25 0.0423
60 BLOOD STEM CELL TRANSPLANT FAILURE 9 0.0419
61 MUCOSAL TOXICITY 11 0.0406
62 PERIPHLEBITIS 3 0.0405
63 STAPHYLOCOCCAL SCALDED SKIN SYNDROME 9 0.0400
64 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 52 0.0395
65 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 8 0.0394
66 DEVICE RELATED BACTERAEMIA 12 0.0387
67 PARVOVIRUS INFECTION 15 0.0371
68 OVARIAN EPITHELIAL CANCER RECURRENT 2 0.0370
69 ORAL LICHENOID REACTION 4 0.0367
70 SEVERE ACUTE RESPIRATORY SYNDROME 8 0.0364
71 VARICELLA VIRUS TEST POSITIVE 6 0.0353
72 HERPES SIMPLEX TEST POSITIVE 7 0.0352
73 GRAFT VERSUS HOST DISEASE IN LIVER 25 0.0349
74 VIRAL DIARRHOEA 12 0.0349
75 EPSTEIN-BARR VIRAEMIA 38 0.0343
76 BRAIN SARCOMA 1 0.0333
77 RETINAL INFILTRATES 2 0.0328
78 CYTOMEGALOVIRUS URINARY TRACT INFECTION 1 0.0323
79 GROWTH FAILURE 11 0.0320
80 SIGHT DISABILITY 6 0.0316
81 ADENOVIRUS TEST POSITIVE 3 0.0316
82 GRAFT VERSUS HOST DISEASE ORAL 2 0.0312
83 ACUTE GRAFT VERSUS HOST DISEASE 139 0.0303
84 GRAFT VERSUS HOST DISEASE IN EYE 7 0.0303
85 ASCARIASIS 1 0.0303
86 BRONCHIOLITIS OBLITERANS SYNDROME 5 0.0286
87 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 24 0.0285
88 DYSBACTERIOSIS 6 0.0280
89 RESPIRATORY TRACT INFLAMMATION 13 0.0279
90 CNS VENTRICULITIS 9 0.0276
91 VIRAEMIA 38 0.0274
92 ORAL MUCOSA HAEMATOMA 2 0.0274
93 INFECTION REACTIVATION 31 0.0271
94 HUMAN BOCAVIRUS INFECTION 5 0.0265
95 NOROVIRUS INFECTION 38 0.0263
96 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 6 0.0261
97 GASTROENTERITIS ROTAVIRUS 8 0.0260
98 GROWTH DISORDER 7 0.0259
99 CITROBACTER INFECTION 11 0.0256
100 BK VIRUS INFECTION 86 0.0255
101 BACTERIAL TRANSLOCATION 8 0.0252
102 LEUKAEMIC INFILTRATION BRAIN 1 0.0250
103 CEREBRAL TOXOPLASMOSIS 23 0.0246
104 CANDIDA SEROLOGY POSITIVE 1 0.0244
105 KLEBSIELLA BACTERAEMIA 23 0.0242
106 VARICELLA ZOSTER VIRUS INFECTION 50 0.0241
107 CHORIORETINAL SCAR 2 0.0241
108 RETINAL SCAR 11 0.0239
109 HERPES SIMPLEX REACTIVATION 9 0.0236
110 AUTOINFLAMMATORY DISEASE 5 0.0236
111 GRAFT VERSUS HOST DISEASE IN LUNG 11 0.0230
112 CYTOMEGALOVIRUS CHORIORETINITIS 44 0.0225
113 INFECTIVE THROMBOSIS 2 0.0225
114 BACILLUS CALMETTE-GUERIN INFECTION 1 0.0222
115 LEPTOTRICHIA INFECTION 1 0.0222
116 PARENTERAL NUTRITION 5 0.0216
117 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 7 0.0213
118 ADENOVIRAL HEPATITIS 5 0.0213
119 ENGRAFT FAILURE 6 0.0209
120 B PRECURSOR TYPE ACUTE LEUKAEMIA 8 0.0206
121 CYTOMEGALOVIRUS VIRAEMIA 90 0.0202
122 ACUTE DISSEMINATED ENCEPHALOMYELITIS 7 0.0202
123 CLONAL EVOLUTION 2 0.0192
124 VENOOCCLUSIVE LIVER DISEASE 95 0.0192
125 BETA 2 MICROGLOBULIN INCREASED 5 0.0192
126 CHRONIC GRAFT VERSUS HOST DISEASE 69 0.0191
127 ALLOGENIC STEM CELL TRANSPLANTATION 3 0.0190
128 INFLUENZA VIRUS TEST POSITIVE 4 0.0190
129 BILIARY ISCHAEMIA 1 0.0189
130 ENCEPHALITIS CYTOMEGALOVIRUS 8 0.0183
131 MORAXELLA INFECTION 5 0.0182
132 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 13 0.0181
133 PNEUMOCYSTIS JIROVECII INFECTION 21 0.0176
134 POST-DEPLETION B-CELL RECOVERY 2 0.0175
135 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 3 0.0173
136 LICHENIFICATION 7 0.0170
137 POLYOMAVIRUS TEST POSITIVE 2 0.0169
138 POLYOMAVIRUS VIRAEMIA 18 0.0169
139 VENOOCCLUSIVE DISEASE 42 0.0168
140 HEPATIC INFECTION FUNGAL 2 0.0167
141 ROSEOLOVIRUS TEST POSITIVE 2 0.0164
142 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 4 0.0163
143 CUTANEOUS MUCORMYCOSIS 3 0.0163
144 HYPERFERRITINAEMIA 7 0.0162
145 CYTOMEGALOVIRUS INFECTION 262 0.0157
146 TYPHOID FEVER 5 0.0157
147 ACINETOBACTER SEPSIS 1 0.0156
148 EPSTEIN-BARR VIRUS INFECTION 97 0.0155
149 TOXIC ERYTHEMA OF CHEMOTHERAPY 4 0.0154
150 LIP ULCERATION 18 0.0154
151 CAPILLARY PERMEABILITY INCREASED 1 0.0154
152 GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0154
153 GASTROENTERITIS NOROVIRUS 20 0.0150
154 ENCEPHALITIS VIRAL 18 0.0148
155 T-LYMPHOCYTE COUNT DECREASED 10 0.0147
156 SOFT TISSUE SARCOMA 5 0.0143
157 GASTROINTESTINAL CANDIDIASIS 6 0.0143
158 TRANSPLANTATION COMPLICATION 6 0.0143
159 PRIMARY HYPOTHYROIDISM 3 0.0142
160 HUMAN HERPESVIRUS 6 ENCEPHALITIS 4 0.0141
161 GRAFT VERSUS HOST DISEASE 101 0.0140
162 CYTOMEGALOVIRUS GASTROENTERITIS 3 0.0139
163 ARTHRITIS FUNGAL 1 0.0139
164 AUTOIMMUNE HAEMOLYTIC ANAEMIA 47 0.0137
165 POSTURAL TREMOR 4 0.0137
166 STEROID DEPENDENCE 12 0.0137
167 GRAFT COMPLICATION 8 0.0136
168 CYTOMEGALOVIRUS COLITIS 31 0.0135
169 GASTROINTESTINAL VIRAL INFECTION 14 0.0134
170 STENOTROPHOMONAS INFECTION 18 0.0133
171 BLOOD BRAIN BARRIER DEFECT 2 0.0132
172 CORNEAL LESION 4 0.0130
173 RETINAL INJURY 10 0.0130
174 PAROTITIS 15 0.0129
175 PNEUMONIA CYTOMEGALOVIRAL 25 0.0129
176 COLD TYPE HAEMOLYTIC ANAEMIA 3 0.0128
177 MINIMAL RESIDUAL DISEASE 6 0.0124
178 CENTRAL HYPOTHYROIDISM 4 0.0121
179 PSEUDOMONAL SEPSIS 21 0.0120
180 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 11 0.0119
181 LOWER RESPIRATORY TRACT INFECTION VIRAL 6 0.0119
182 IDIOPATHIC GENERALISED EPILEPSY 1 0.0118
183 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 3 0.0118
184 GASTROENTERITIS SAPOVIRUS 1 0.0115
185 BLASTOCYSTIS INFECTION 1 0.0115
186 PNEUMONITIS CHEMICAL 4 0.0115
187 AUTOIMMUNE ENTEROPATHY 1 0.0114
188 PHARYNGEAL ULCERATION 15 0.0113
189 BACTERIAL COLITIS 2 0.0111
190 FEEDING INTOLERANCE 5 0.0111
191 ANAL ULCER 9 0.0110
192 DYSBIOSIS 9 0.0110
193 B-LYMPHOCYTE COUNT INCREASED 2 0.0108
194 IMMUNE THROMBOCYTOPENIA 49 0.0107
195 CAPILLARY LEAK SYNDROME 22 0.0106
196 CEREBRAL FUNGAL INFECTION 3 0.0106
197 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0105
198 ROTAVIRUS INFECTION 6 0.0104
199 ENTEROCOCCAL BACTERAEMIA 11 0.0104
200 INTERSTITIAL GRANULOMATOUS DERMATITIS 2 0.0104
201 HEPATITIS INFECTIOUS MONONUCLEOSIS 1 0.0103
202 STREPTOCOCCAL BACTERAEMIA 11 0.0101
203 HYPERCREATININAEMIA 5 0.0099
204 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 49 0.0096
205 TRANSPLANT FAILURE 23 0.0094
206 CORONA VIRUS INFECTION 4 0.0093
207 MUCOSAL INFLAMMATION 243 0.0093
208 MOLLUSCUM CONTAGIOSUM 5 0.0093
209 SKIN TOXICITY 52 0.0092
210 CYSTITIS HAEMORRHAGIC 37 0.0092
211 GASTROENTERITIS ESCHERICHIA COLI 5 0.0091
212 BONE MARROW TRANSPLANT REJECTION 2 0.0091
213 VANISHING BILE DUCT SYNDROME 10 0.0090
214 DECEREBRATION 1 0.0088
215 PNEUMATOSIS INTESTINALIS 25 0.0088
216 SOFT TISSUE INFECTION 16 0.0087
217 HAIRY CELL LEUKAEMIA 2 0.0086
218 FUSARIUM INFECTION 6 0.0086
219 RETINAL EXUDATES 8 0.0085
220 CYTOMEGALOVIRUS ENTERITIS 3 0.0084
221 AGNOSIA 2 0.0084
222 MYCOBACTERIUM ABSCESSUS INFECTION 6 0.0084
223 HERPES SIMPLEX 54 0.0083
224 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 3 0.0082
225 OSMOTIC DEMYELINATION SYNDROME 6 0.0081
226 STAPHYLOCOCCAL SKIN INFECTION 10 0.0081
227 EVANS SYNDROME 4 0.0081
228 WEST NILE VIRAL INFECTION 6 0.0080
229 PARAINFLUENZAE VIRUS INFECTION 12 0.0079
230 CYSTITIS VIRAL 3 0.0078
231 B-CELL APLASIA 2 0.0078
232 HERPES ZOSTER REACTIVATION 2 0.0076
233 TOXIC NEUROPATHY 3 0.0076
234 PULMONARY MUCORMYCOSIS 4 0.0076
235 HERPES ZOSTER DISSEMINATED 6 0.0075
236 GENITAL DISORDER 1 0.0075
237 HAEMATOLOGICAL INFECTION 18 0.0074
238 NEUTROPENIC COLITIS 15 0.0072
239 POIKILOCYTOSIS 2 0.0072
240 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 36 0.0072
241 CHLOROMA 3 0.0071
242 KLEBSIELLA SEPSIS 8 0.0071
243 CAROTID ARTERY THROMBOSIS 6 0.0071
244 INTENTION TREMOR 4 0.0070
245 HEPATOPULMONARY SYNDROME 1 0.0070
246 RETINITIS 12 0.0069
247 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 66 0.0069
248 COLLATERAL CIRCULATION 1 0.0069
249 GRAFT LOSS 5 0.0069
250 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 50 0.0067
251 IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME 1 0.0066
252 DYSMETRIA 4 0.0066
253 ENTEROCOLITIS INFECTIOUS 6 0.0065
254 TRANSFUSION-RELATED ACUTE LUNG INJURY 2 0.0065
255 ABSCESS SOFT TISSUE 1 0.0065
256 HERPES SIMPLEX ENCEPHALITIS 3 0.0065
257 CONGENITAL APLASIA 2 0.0064
258 METAPNEUMOVIRUS INFECTION 5 0.0064
259 ASPERGILLOMA 2 0.0063
260 PARAKERATOSIS 2 0.0062
261 SECONDARY HYPOGONADISM 2 0.0061
262 CYTOMEGALOVIRUS SYNDROME 1 0.0061
263 PNEUMONIA INFLUENZAL 7 0.0059
264 THROMBOTIC MICROANGIOPATHY 57 0.0058
265 ACUTE MYELOID LEUKAEMIA REFRACTORY 1 0.0058
266 TRIGEMINAL NERVE DISORDER 2 0.0057
267 CRYPTOSPORIDIOSIS INFECTION 3 0.0057
268 SCEDOSPORIUM INFECTION 4 0.0057
269 CHRONIC RESPIRATORY DISEASE 2 0.0057
270 DRUG-GENETIC INTERACTION 2 0.0056
271 BONE NEOPLASM 6 0.0056
272 COMPLICATIONS OF BONE MARROW TRANSPLANT 2 0.0055
273 CHRONIC MYELOID LEUKAEMIA RECURRENT 3 0.0055
274 ASPERGILLUS INFECTION 36 0.0055
275 HERPES SIMPLEX OESOPHAGITIS 1 0.0054
276 NAIL DYSTROPHY 3 0.0054
277 HYPOGAMMAGLOBULINAEMIA 35 0.0053
278 MICROANGIOPATHY 5 0.0053
279 BACTERIAL SEPSIS 17 0.0052
280 CRYPTOGENIC ORGANIZING PNEUMONIA 1 0.0052
281 EYE INFECTION FUNGAL 2 0.0052
282 IDIOSYNCRATIC DRUG REACTION 5 0.0051
283 CENTRAL NERVOUS SYSTEM LEUKAEMIA 2 0.0051
284 STAPHYLOCOCCAL BACTERAEMIA 22 0.0051
285 JUGULAR VEIN THROMBOSIS 9 0.0051
286 HEPATORENAL FAILURE 3 0.0050
287 PNEUMOMEDIASTINUM 9 0.0050
288 LYMPHOCYTIC INFILTRATION 5 0.0050
289 TRICHOSPORON INFECTION 2 0.0049
290 GASTROENTERITIS CRYPTOSPORIDIAL 1 0.0049
291 TRANSPLANT REJECTION 39 0.0049
292 ESCHERICHIA SEPSIS 14 0.0048
293 BACTERIAL DIARRHOEA 1 0.0047
294 ACUTE MYELOID LEUKAEMIA RECURRENT 10 0.0047
295 ENTEROVIRUS INFECTION 4 0.0046
296 MULTIPLE ORGAN DYSFUNCTION SYNDROME 130 0.0046
297 FACIAL NERVE DISORDER 2 0.0045
298 PNEUMATOSIS 2 0.0045
299 ACUTE LEFT VENTRICULAR FAILURE 3 0.0045
300 JC VIRUS INFECTION 7 0.0044
301 EPIDERMOLYSIS 2 0.0043
302 ENTEROCOLITIS 25 0.0043
303 ZYGOMYCOSIS 2 0.0043
304 RESTRICTIVE PULMONARY DISEASE 5 0.0043
305 PROTEUS INFECTION 3 0.0042
306 LEUKAEMIA RECURRENT 7 0.0041
307 PHARYNGEAL INFLAMMATION 5 0.0041
308 PARESIS 9 0.0040
309 PROTEIN-LOSING GASTROENTEROPATHY 2 0.0040
310 DEVICE RELATED SEPSIS 8 0.0040
311 ERYTHEMA INFECTIOSUM 1 0.0039
312 LEUKOPLAKIA ORAL 2 0.0039
313 STAPHYLOCOCCAL SEPSIS 19 0.0038
314 RETINAL HAEMORRHAGE 27 0.0038
315 HUMAN POLYOMAVIRUS INFECTION 2 0.0038
316 VARICELLA 9 0.0038
317 EAR INFECTION BACTERIAL 1 0.0037
318 HYPOALDOSTERONISM 1 0.0036
319 LIMBIC ENCEPHALITIS 1 0.0036
320 BRONCHOPULMONARY ASPERGILLOSIS 28 0.0036
321 STEM CELL TRANSPLANT 9 0.0036
322 LIFE SUPPORT 2 0.0036
323 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 9 0.0035
324 MUCOSAL HAEMORRHAGE 4 0.0034
325 RESPIRATORY TRACT INFECTION VIRAL 8 0.0034
326 LYMPHOPROLIFERATIVE DISORDER 10 0.0034
327 BREAST ENGORGEMENT 1 0.0034
328 OESOPHAGEAL ULCER 13 0.0034
329 ACUTE LUNG INJURY 4 0.0034
330 CAMPYLOBACTER GASTROENTERITIS 2 0.0034
331 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 1 0.0034
332 SECONDARY ADRENOCORTICAL INSUFFICIENCY 5 0.0033
333 LYMPHADENITIS 8 0.0033
334 PSEUDOMONAS INFECTION 28 0.0033
335 VITRITIS 6 0.0032
336 ACUTE LYMPHOCYTIC LEUKAEMIA 9 0.0032
337 BOWEL SOUNDS ABNORMAL 1 0.0032
338 PNEUMONIA VIRAL 10 0.0031
339 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5 0.0031
340 IATROGENIC INJURY 4 0.0031
341 AUTOIMMUNE COLITIS 2 0.0031
342 SUSPECTED OFF LABEL USE 14 0.0031
343 FASCIITIS 2 0.0030
344 ANISOCYTOSIS 2 0.0030
345 GASTRIC DILATATION 5 0.0030
346 LYMPHOPENIA 42 0.0030
347 KLEBSIELLA INFECTION 15 0.0030
348 CYSTITIS BACTERIAL 1 0.0030
349 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 18 0.0030
350 HEPATITIS C RNA INCREASED 1 0.0029
351 SUBDURAL HAEMORRHAGE 8 0.0029
352 CORONAVIRUS TEST POSITIVE 3 0.0029
353 ENCEPHALITIS 20 0.0029
354 ACUTE RESPIRATORY DISTRESS SYNDROME 51 0.0029
355 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 1 0.0029
356 GASTROENTERITIS CLOSTRIDIAL 1 0.0028
357 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 5 0.0028
358 GASTROINTESTINAL OEDEMA 5 0.0028
359 CYTOMEGALOVIRUS HEPATITIS 1 0.0028
360 SYSTEMIC CANDIDA 7 0.0028
361 EOSINOPHILIC COLITIS 1 0.0027
362 ENTEROBACTER SEPSIS 1 0.0027
363 HEPATOSPLENIC T-CELL LYMPHOMA 1 0.0027
364 LEUKOENCEPHALOPATHY 10 0.0027
365 OSTEOPOROTIC FRACTURE 5 0.0026
366 PNEUMONIA PSEUDOMONAL 4 0.0026
367 SYSTEMIC MYCOSIS 3 0.0026
368 CONGENITAL DIAPHRAGMATIC HERNIA 1 0.0026
369 DISSEMINATED MUCORMYCOSIS 1 0.0025
370 PNEUMONIA STAPHYLOCOCCAL 5 0.0025
371 ENTEROCOCCAL INFECTION 12 0.0025
372 BLOOD URIC ACID ABNORMAL 1 0.0025
373 AUTOIMMUNE HEPATITIS 17 0.0024
374 FUNGAL SEPSIS 2 0.0024
375 PNEUMONITIS 65 0.0024
376 ENTEROBACTER INFECTION 4 0.0024
377 JC VIRUS TEST POSITIVE 2 0.0024
378 BRAIN ABSCESS 6 0.0024
379 NECROTISING COLITIS 3 0.0024
380 BACTERAEMIA 28 0.0024
381 RHINOVIRUS INFECTION 9 0.0023
382 PERICARDIAL HAEMORRHAGE 5 0.0023
383 GUILLAIN-BARRE SYNDROME 11 0.0023
384 HERPES VIRUS INFECTION 13 0.0023
385 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
386 TRANSPLANT DYSFUNCTION 4 0.0022
387 CANDIDA SEPSIS 2 0.0022
388 VASCULAR DEVICE INFECTION 10 0.0022
389 BONE INFARCTION 1 0.0022
390 ESCHERICHIA INFECTION 18 0.0022
391 LOCKED-IN SYNDROME 1 0.0022
392 NEUROLOGICAL DECOMPENSATION 5 0.0022
393 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 1 0.0021
394 ATYPICAL MYCOBACTERIAL INFECTION 3 0.0021
395 GASTROINTESTINAL INFECTION 19 0.0021
396 TRACHEOSTOMY 3 0.0021
397 NEUTROPENIC INFECTION 2 0.0021
398 STAPHYLOCOCCAL INFECTION 69 0.0021
399 DIABETES INSIPIDUS 5 0.0021
400 PULMONARY SEPSIS 3 0.0021
401 EPIDERMAL NECROSIS 2 0.0021
402 CYTOPENIA 25 0.0020
403 MASTOIDITIS 2 0.0020
404 GROWTH RETARDATION 6 0.0020
405 PNEUMONIA FUNGAL 8 0.0020
406 STEROID WITHDRAWAL SYNDROME 2 0.0020
407 HEPATOSPLENOMEGALY 5 0.0019
408 FAECAL VOLUME INCREASED 1 0.0019
409 IMMUNE-MEDIATED ENCEPHALITIS 1 0.0019
410 CORYNEBACTERIUM INFECTION 1 0.0019
411 CD4 LYMPHOCYTES DECREASED 4 0.0019
412 MYELODYSPLASTIC SYNDROME 27 0.0019
413 HYPERBILIRUBINAEMIA 19 0.0018
414 ACINETOBACTER INFECTION 2 0.0018
415 PULMONARY HAEMORRHAGE 14 0.0018
416 PULMONARY ALVEOLAR HAEMORRHAGE 10 0.0018
417 PIGMENTATION DISORDER 11 0.0018
418 IMMUNE THROMBOCYTOPENIC PURPURA 5 0.0018
419 CENTRAL NERVOUS SYSTEM INFECTION 2 0.0017
420 PANCREATITIS NECROTISING 4 0.0017
421 CYTOMEGALOVIRUS TEST POSITIVE 3 0.0017
422 ACUTE MYELOID LEUKAEMIA 26 0.0017
423 RECTAL PROLAPSE 2 0.0017
424 HYDROCEPHALUS 9 0.0017
425 CAROTID ARTERY OCCLUSION 6 0.0016
426 HUMAN HERPESVIRUS 8 INFECTION 1 0.0016
427 METAMORPHOPSIA 3 0.0016
428 ANGIOPATHY 9 0.0016
429 EPSTEIN-BARR VIRUS TEST POSITIVE 1 0.0016
430 MYELOPATHY 3 0.0016
431 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6 0.0016
432 BLOOD BILIRUBIN ABNORMAL 2 0.0016
433 ABDOMINAL WALL ABSCESS 1 0.0015
434 KLEBSIELLA TEST POSITIVE 1 0.0015
435 ORAL INFECTION 6 0.0015
436 APLASTIC ANAEMIA 8 0.0015
437 LUNG OPACITY 4 0.0015
438 CHRONIC MYELOMONOCYTIC LEUKAEMIA 1 0.0015
439 ANAL FISTULA 8 0.0015
440 BRONCHITIS VIRAL 1 0.0015
441 FEBRILE NEUTROPENIA 98 0.0015
442 NEPHROTIC SYNDROME 10 0.0015
443 IMMUNOGLOBULINS DECREASED 2 0.0015
444 PERICARDIAL EFFUSION 33 0.0014
445 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0014
446 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
447 DRUG RESISTANCE 36 0.0014
448 INFECTION IN AN IMMUNOCOMPROMISED HOST 1 0.0014
449 VIRAL INFECTION 46 0.0014
450 CUTANEOUS VASCULITIS 5 0.0014
451 HAEMATOTOXICITY 13 0.0014
452 CANDIDA INFECTION 23 0.0014
453 COMA HEPATIC 1 0.0013
454 FAILURE TO THRIVE 7 0.0013
455 BRAIN STEM SYNDROME 1 0.0013
456 BONE MARROW DISORDER 4 0.0013
457 AUTOIMMUNE THYROIDITIS 5 0.0013
458 OPTIC NEURITIS 12 0.0013
459 NEUROTOXICITY 23 0.0013
460 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
461 HYPERTROPHIC CARDIOMYOPATHY 2 0.0013
462 RENAL FUNCTION TEST ABNORMAL 6 0.0013
463 HYPOALBUMINAEMIA 10 0.0013
464 ASEPTIC NECROSIS BONE 1 0.0013
465 ESCHERICHIA BACTERAEMIA 3 0.0013
466 DIARRHOEA INFECTIOUS 1 0.0013
467 RESPIRATORY SYNCYTIAL VIRUS INFECTION 11 0.0013
468 ENCEPHALOPATHY 31 0.0013
469 VIRAL UPPER RESPIRATORY TRACT INFECTION 6 0.0013
470 ENTERITIS 8 0.0012
471 GASTROINTESTINAL TOXICITY 6 0.0012
472 NEPHROPATHY TOXIC 14 0.0012
473 HEPATITIS VIRAL 1 0.0012
474 VISUAL FIELD DEFECT 9 0.0012
475 ENTEROCOCCAL SEPSIS 1 0.0012
476 AUTOIMMUNE DISORDER 12 0.0012
477 CRYPTOCOCCOSIS 2 0.0012
478 HEPATIC FAILURE 37 0.0012
479 CLOSTRIDIUM DIFFICILE COLITIS 13 0.0012
480 HYPERURICAEMIA 5 0.0012
481 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 10 0.0012
482 SYSTEMIC INFECTION 2 0.0012
483 SALMONELLOSIS 2 0.0012
484 TOXIC EPIDERMAL NECROLYSIS 18 0.0012
485 NEOPLASM RECURRENCE 4 0.0012
486 IMPAIRED GASTRIC EMPTYING 16 0.0012
487 ASCITES 34 0.0012
488 ABDOMINAL LYMPHADENOPATHY 1 0.0012
489 HYPERREFLEXIA 4 0.0011
490 ACUTE RESPIRATORY FAILURE 22 0.0011
491 FUNGAL INFECTION 38 0.0011
492 PARONYCHIA 5 0.0011
493 HEPATOTOXICITY 25 0.0011
494 ABDOMINAL NEOPLASM 1 0.0011
495 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
496 MULTI-ORGAN FAILURE 19 0.0011
497 HAEMOCHROMATOSIS 1 0.0011
498 OPPORTUNISTIC INFECTION 2 0.0011
499 PROCTITIS 3 0.0011
500 NEUTROPHIL COUNT ABNORMAL 3 0.0011
501 LIP DISORDER 2 0.0011
502 NEUROLOGICAL SYMPTOM 6 0.0010
503 ANURIA 9 0.0010
504 CHOLECYSTITIS CHRONIC 7 0.0010
505 AGITATION NEONATAL 1 0.0010
506 MYOPATHY 9 0.0010
507 BONE MARROW DEPRESSION 1 0.0010
508 LUNG INFILTRATION 9 0.0010
509 DEVICE RELATED THROMBOSIS 1 0.0010
510 SEPSIS 113 0.0010
511 BRAIN HERNIATION 3 0.0010
512 DERMATITIS EXFOLIATIVE 5 0.0010
513 ILEAL ULCER 1 0.0010
514 CACHEXIA 5 0.0010
515 CHOLESTASIS 18 0.0009
516 CUSHINGOID 3 0.0009
517 STUPOR 3 0.0009
518 SKIN EROSION 3 0.0009
519 HEPATIC LESION 4 0.0009
520 PLASMA CELL MYELOMA RECURRENT 3 0.0009
521 PRODUCT USE IN UNAPPROVED INDICATION 228 0.0009
522 RESPIRATORY FAILURE 67 0.0009
523 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
524 ACARODERMATITIS 1 0.0009
525 DEAFNESS NEUROSENSORY 3 0.0009
526 CORONAVIRUS INFECTION 6 0.0009
527 MALNUTRITION 10 0.0009
528 BRONCHIECTASIS 6 0.0009
529 GASTROENTERITIS VIRAL 16 0.0009
530 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 48 0.0009
531 APLASIA PURE RED CELL 3 0.0009
532 PNEUMONIA BACTERIAL 8 0.0009
533 RESPIRATORY DISTRESS 24 0.0009
534 NEUTROPENIA 117 0.0009
535 ABNORMAL FAECES 7 0.0009
536 HYPOCALCAEMIA 16 0.0008
537 THERAPY NON-RESPONDER 38 0.0008
538 BONE MARROW TOXICITY 1 0.0008
539 ESCHERICHIA TEST POSITIVE 1 0.0008
540 BILE DUCT STENOSIS 1 0.0008
541 HYPERTHYROIDISM 12 0.0008
542 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
543 BREATH ODOUR 2 0.0008
544 ORAL DISORDER 6 0.0008
545 VITREOUS FLOATERS 8 0.0008
546 HYPOPHOSPHATAEMIA 6 0.0008
547 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 1 0.0008
548 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 2 0.0008
549 THROMBOCYTOPENIA 90 0.0008
550 ILEUS 10 0.0008
551 BACTERIAL INFECTION 15 0.0008
552 CYTOKINE RELEASE SYNDROME 16 0.0008
553 ERYSIPELAS 4 0.0008
554 BRAIN OEDEMA 10 0.0008
555 TOXIC ENCEPHALOPATHY 4 0.0008
556 OFF LABEL USE 687 0.0008
557 LEUKOPENIA 39 0.0008
558 DIFFUSE LARGE B-CELL LYMPHOMA 6 0.0008
559 LYMPHOMA 12 0.0008
560 MUCORMYCOSIS 2 0.0008
561 GASTROINTESTINAL INFLAMMATION 6 0.0008
562 ASPERGILLOSIS 1 0.0008
563 ACQUIRED GENE MUTATION 1 0.0008
564 COVID-19 PNEUMONIA 9 0.0008
565 AGRANULOCYTOSIS 14 0.0008
566 CANDIDIASIS 3 0.0007
567 FUNGAL SKIN INFECTION 3 0.0007
568 GLYCOSURIA 1 0.0007
569 DISEASE RECURRENCE 35 0.0007
570 HAEMORRHAGE INTRACRANIAL 11 0.0007
571 RECURRENT CANCER 3 0.0007
572 PANCREATITIS ACUTE 16 0.0007
573 INTENTIONAL PRODUCT USE ISSUE 62 0.0007
574 FANCONI SYNDROME 1 0.0007
575 OXYGEN SATURATION ABNORMAL 2 0.0007
576 INTENSIVE CARE 1 0.0007
577 HYPERTONIA 4 0.0007
578 PNEUMOCYSTIS JIROVECII PNEUMONIA 7 0.0007
579 ACUTE ABDOMEN 1 0.0007
580 APRAXIA 1 0.0007
581 ATAXIA 8 0.0007
582 RENAL IMPAIRMENT 56 0.0007
583 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
584 DEVICE RELATED INFECTION 10 0.0006
585 HAEMOLYSIS 5 0.0006
586 BRAIN DEATH 2 0.0006
587 SEPTIC SHOCK 27 0.0006
588 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 2 0.0006
589 INFLAMMATORY MARKER INCREASED 3 0.0006
590 HYPERNATRAEMIA 3 0.0006
591 NEPHRITIS 2 0.0006
592 QUALITY OF LIFE DECREASED 8 0.0006
593 TOXIC SKIN ERUPTION 6 0.0006
594 STOMATITIS 36 0.0006
595 HEPATORENAL SYNDROME 1 0.0006
596 DEAFNESS BILATERAL 1 0.0006
597 ENTERITIS INFECTIOUS 1 0.0006
598 GLIOBLASTOMA 1 0.0006
599 POLYNEUROPATHY 7 0.0006
600 BLOOD AMYLASE INCREASED 1 0.0006
601 SKIN LESION 16 0.0006
602 THERAPY PARTIAL RESPONDER 9 0.0006
603 MALABSORPTION 3 0.0006
604 EXTREMITY NECROSIS 1 0.0006
605 PANCYTOPENIA 32 0.0006
606 TUMOUR LYSIS SYNDROME 5 0.0006
607 BRONCHIOLITIS 2 0.0006
608 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
609 METABOLIC ACIDOSIS 18 0.0006
610 HAEMORRHAGIC DIATHESIS 2 0.0006
611 MYOSITIS 5 0.0006
612 BONE LESION 2 0.0006
613 PATHOGEN RESISTANCE 5 0.0005
614 SKIN HAEMORRHAGE 8 0.0005
615 CATHETER PLACEMENT 1 0.0005
616 INTRACRANIAL PRESSURE INCREASED 3 0.0005
617 DIARRHOEA HAEMORRHAGIC 5 0.0005
618 CYSTOID MACULAR OEDEMA 1 0.0005
619 TONGUE OEDEMA 2 0.0005
620 METASTASES TO LUNG 6 0.0005
621 ELECTROLYTE IMBALANCE 6 0.0005
622 CARDIOPULMONARY FAILURE 2 0.0005
623 RENAL TUBULAR NECROSIS 5 0.0005
624 BRADYKINESIA 3 0.0005
625 HYPERAEMIA 1 0.0005
626 AZOTAEMIA 2 0.0005
627 DISEASE PROGRESSION 58 0.0005
628 HERPES ZOSTER 28 0.0005
629 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
630 SECOND PRIMARY MALIGNANCY 4 0.0005
631 HEMIPLEGIA 4 0.0005
632 COAGULOPATHY 8 0.0005
633 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
634 ACUTE KIDNEY INJURY 72 0.0005
635 HEPATITIS 12 0.0005
636 ANAPHYLACTIC SHOCK 12 0.0005
637 ORAL HERPES 9 0.0005
638 GASTRITIS 12 0.0005
639 INFECTION 66 0.0005
640 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
641 DRUG ERUPTION 8 0.0005
642 CARDIAC FAILURE ACUTE 3 0.0004
643 ILEUS PARALYTIC 2 0.0004
644 PAPILLOEDEMA 2 0.0004
645 BONE MARROW FAILURE 9 0.0004
646 LICHENOID KERATOSIS 1 0.0004
647 CENTRAL NERVOUS SYSTEM LESION 6 0.0004
648 EYELID DISORDER 1 0.0004
649 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
650 HYPOPHAGIA 11 0.0004
651 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
652 HEPATIC ENCEPHALOPATHY 4 0.0004
653 SPLENOMEGALY 5 0.0004
654 METASTASIS 3 0.0004
655 IMPAIRED QUALITY OF LIFE 6 0.0004
656 PRODUCT USE ISSUE 78 0.0004
657 JUVENILE IDIOPATHIC ARTHRITIS 1 0.0004
658 LIVER DISORDER 18 0.0004
659 HYPERCALCAEMIA 5 0.0004
660 HYPERVOLAEMIA 2 0.0004
661 BRAIN INJURY 4 0.0004
662 DERMATOMYOSITIS 1 0.0004
663 HAEMORRHAGE URINARY TRACT 1 0.0004
664 ISCHAEMIC STROKE 7 0.0004
665 BLOOD CHLORIDE DECREASED 1 0.0004
666 PERITONITIS 8 0.0004
667 CONVULSION 22 0.0004
668 PYREXIA 132 0.0004
669 POLYARTHRITIS 2 0.0004
670 ABDOMINAL MASS 1 0.0004
671 BLOOD BILIRUBIN INCREASED 10 0.0004
672 GASTRIC PERFORATION 1 0.0004
673 OESOPHAGITIS 4 0.0004
674 SPINAL COMPRESSION FRACTURE 3 0.0004
675 COLITIS ULCERATIVE 16 0.0004
676 ENDOTRACHEAL INTUBATION 1 0.0004
677 CHOLECYSTITIS ACUTE 2 0.0004
678 FACIAL PARALYSIS 3 0.0004
679 CYSTITIS 11 0.0003
680 PLEURAL EFFUSION 21 0.0003
681 URINE OUTPUT DECREASED 3 0.0003
682 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
683 OSTEOPOROSIS 14 0.0003
684 IMMUNOSUPPRESSION 3 0.0003
685 EAR INFECTION 9 0.0003
686 PLEURISY 2 0.0003
687 CARDIAC FAILURE 27 0.0003
688 PULMONARY HYPERTENSION 7 0.0003
689 ATYPICAL PNEUMONIA 1 0.0003
690 EMBOLISM VENOUS 1 0.0003
691 DYSAESTHESIA 1 0.0003
692 RENAL FAILURE 43 0.0003
693 OSTEONECROSIS OF JAW 8 0.0003
694 RASH MACULO-PAPULAR 7 0.0003
695 LYMPHADENOPATHY 11 0.0003
696 PLASMA CELL MYELOMA 12 0.0003
697 C-REACTIVE PROTEIN INCREASED 11 0.0003
698 SKIN MASS 2 0.0003
699 MENINGITIS 2 0.0003
700 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
701 CLOSTRIDIAL INFECTION 1 0.0003
702 EPILEPSY 9 0.0003
703 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
704 NEUTROPHIL COUNT INCREASED 3 0.0003
705 ACUTE HEPATIC FAILURE 4 0.0003
706 HEPATIC FIBROSIS 1 0.0003
707 TREATMENT FAILURE 24 0.0003
708 BLOOD CREATININE ABNORMAL 1 0.0003
709 DEPRESSION SUICIDAL 1 0.0003
710 LARGE INTESTINE PERFORATION 2 0.0003
711 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
712 DRUG-INDUCED LIVER INJURY 9 0.0003
713 DEPRESSIVE SYMPTOM 1 0.0003
714 FACIAL PARESIS 1 0.0003
715 HYPERTENSION 59 0.0003
716 MYELOSUPPRESSION 10 0.0003
717 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
718 DERMATITIS BULLOUS 2 0.0003
719 LIVER TRANSPLANT 1 0.0003
720 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
721 VISUAL ACUITY REDUCED 9 0.0003
722 PULMONARY OEDEMA 12 0.0003
723 STATUS EPILEPTICUS 3 0.0003
724 CATHETER SITE INFECTION 1 0.0003
725 HAEMODYNAMIC INSTABILITY 2 0.0003
726 HYPOKALAEMIA 12 0.0003
727 COGNITIVE DISORDER 12 0.0003
728 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
729 ABSCESS 4 0.0003
730 CEREBRAL INFARCTION 6 0.0002
731 OSTEONECROSIS 8 0.0002
732 ANAPHYLACTOID REACTION 1 0.0002
733 GASTROINTESTINAL HAEMORRHAGE 20 0.0002
734 HEPATIC CYTOLYSIS 3 0.0002
735 AORTIC VALVE INCOMPETENCE 1 0.0002
736 CIRCULATORY COLLAPSE 4 0.0002
737 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
738 SKIN HYPERPIGMENTATION 2 0.0002
739 IMMUNE SYSTEM DISORDER 3 0.0002
740 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
741 TRANSAMINASES INCREASED 5 0.0002
742 CARDIOTOXICITY 2 0.0002
743 CEREBRAL HAEMORRHAGE 8 0.0002
744 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
745 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
746 CHRONIC MYELOID LEUKAEMIA 1 0.0002
747 RENAL DISORDER 10 0.0002
748 NEPHROPATHY 2 0.0002
749 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
750 CARDIAC TAMPONADE 1 0.0002
751 RASH ERYTHEMATOUS 10 0.0002
752 ANAEMIA 39 0.0002
753 INFLAMMATORY BOWEL DISEASE 2 0.0002
754 THERAPY CHANGE 2 0.0002
755 PERITONITIS BACTERIAL 2 0.0002
756 HYPONATRAEMIA 11 0.0002
757 NERVOUS SYSTEM DISORDER 6 0.0002
758 DERMATITIS 4 0.0002
759 DRUG INEFFECTIVE 251 0.0002
760 BLOOD LACTIC ACID INCREASED 1 0.0002
761 TOXICITY TO VARIOUS AGENTS 32 0.0002
762 OBESITY 3 0.0002
763 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
764 INTESTINAL RESECTION 1 0.0002
765 ANAL ABSCESS 1 0.0002
766 GINGIVITIS 1 0.0002
767 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
768 ASPIRATION 2 0.0002
769 AUTISM SPECTRUM DISORDER 1 0.0002
770 RASH 78 0.0002
771 SKIN INFECTION 2 0.0002
772 ACUTE PULMONARY OEDEMA 1 0.0002
773 MYOCARDITIS 2 0.0002
774 CHRONIC KIDNEY DISEASE 13 0.0002
775 LABORATORY TEST ABNORMAL 5 0.0002
776 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
777 CHOLECYSTITIS 2 0.0002
778 SKIN EXFOLIATION 14 0.0002
779 APHASIA 5 0.0002
780 ADRENAL INSUFFICIENCY 2 0.0002
781 SEIZURE 19 0.0002
782 ATRIAL FIBRILLATION 16 0.0002
783 RESPIRATORY DEPRESSION 2 0.0002
784 MALIGNANT NEOPLASM PROGRESSION 16 0.0002
785 HAEMOGLOBIN ABNORMAL 1 0.0002
786 INFLAMMATION 8 0.0002
787 DIPLOPIA 4 0.0002
788 VISUAL IMPAIRMENT 19 0.0002
789 TOOTH INFECTION 2 0.0002
790 PNEUMONIA 49 0.0002
791 CATARACT 9 0.0002
792 SKIN DISORDER 5 0.0001
793 JAUNDICE 4 0.0001
794 COLITIS ISCHAEMIC 1 0.0001
795 FEEDING DISORDER 3 0.0001
796 UVEITIS 2 0.0001
797 TACHYPNOEA 2 0.0001
798 COMA 7 0.0001
799 DRUG TOXICITY 2 0.0001
800 MOUTH ULCERATION 3 0.0001
801 BRONCHOSPASM 2 0.0001
802 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
803 BRONCHITIS 10 0.0001
804 RENAL INJURY 4 0.0001
805 PULMONARY MASS 2 0.0001
806 IMMUNODEFICIENCY 2 0.0001
807 DIARRHOEA 86 0.0001
808 HEPATIC ENZYME INCREASED 9 0.0001
809 COLITIS 5 0.0001
810 FOOD ALLERGY 1 0.0001
811 MUSCULOSKELETAL CHEST PAIN 2 0.0001
812 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
813 COVID-19 22 0.0001
814 GASTROINTESTINAL DISORDER 11 0.0001
815 LUNG DISORDER 6 0.0001
816 NASAL CONGESTION 7 0.0001
817 PERICARDITIS 2 0.0001
818 HAEMATURIA 4 0.0001
819 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
820 RESPIRATORY TRACT INFECTION 3 0.0001
821 EOSINOPHILIA 2 0.0001
822 AMENORRHOEA 2 0.0001
823 METASTASES TO LIVER 2 0.0001
824 THROMBOSIS 9 0.0001
825 FEAR 3 0.0001
826 DEVELOPMENTAL DELAY 1 0.0001
827 HAEMATOCHEZIA 6 0.0001
828 ABDOMINAL PAIN 25 0.0001
829 ERYTHEMA MULTIFORME 1 0.0001
830 LEUKAEMIA 1 0.0001
831 PROTEINURIA 2 0.0001
832 ATELECTASIS 1 0.0001
833 ERUCTATION 2 0.0001
834 INTENTIONAL PRODUCT MISUSE 9 0.0001
835 HEPATOMEGALY 1 0.0001
836 BLADDER DISORDER 1 0.0001
837 BLOOD PRESSURE ABNORMAL 2 0.0001
838 SPINAL FRACTURE 2 0.0001
839 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
840 ILL-DEFINED DISORDER 6 0.0001
841 NEUTROPHIL COUNT DECREASED 4 0.0001
842 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
843 VOMITING 45 0.0001
844 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
845 HALLUCINATION 7 0.0001
846 BLOOD CREATININE INCREASED 6 0.0001
847 PRODUCT PRESCRIBING ISSUE 2 0.0001
848 GASTROINTESTINAL PAIN 1 0.0001
849 MELAENA 2 0.0001
850 INTESTINAL PERFORATION 1 0.0001
851 FISTULA 1 0.0001
852 BLOOD CALCIUM DECREASED 1 0.0001
853 SHOCK 2 0.0001
854 HYPERKALAEMIA 3 0.0001
855 INTERSTITIAL LUNG DISEASE 4 0.0001
856 HYPERGLYCAEMIA 3 0.0001
857 CONDITION AGGRAVATED 25 0.0001
858 DERMATITIS ALLERGIC 1 0.0001
859 HAEMOGLOBIN DECREASED 8 0.0001
860 ANOREXIA 1 0.0001
861 RASH GENERALISED 2 0.0001
862 HAEMATOMA 2 0.0001
863 DISORIENTATION 3 0.0001
864 FREQUENT BOWEL MOVEMENTS 2 0.0001
865 OEDEMA 4 0.0001
866 GINGIVAL BLEEDING 1 0.0001
867 RESPIRATORY ARREST 2 0.0001
868 ANAPHYLACTIC REACTION 4 0.0001
869 HAEMOPTYSIS 2 0.0001
870 CARDIOGENIC SHOCK 1 0.0001
871 DRUG INTERACTION 11 0.0001
872 HYPOKINESIA 1 0.0001
873 GASTROENTERITIS 1 0.0001
874 CARDIOMYOPATHY 1 0.0001
875 DEHYDRATION 9 0.0001
876 HAEMORRHAGE 7 0.0001
877 PLATELET COUNT DECREASED 7 0.0001
878 TINNITUS 3 0.0001
879 NAUSEA 50 0.0001
880 LACTIC ACIDOSIS 2 0.0001
881 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
882 BLOOD UREA INCREASED 1 0.0001
883 CELLULITIS 3 0.0001
884 HEMIPARESIS 1 0.0001
885 FLUID RETENTION 3 0.0001
886 URINARY TRACT INFECTION 10 0.0001
887 SINUSITIS 6 0.0001
888 DELIRIUM 2 0.0001
889 MUSCULOSKELETAL PAIN 3 0.0001
890 HYPOXIA 2 0.0001
891 CONFUSIONAL STATE 9 0.0001
892 LEUKOCYTOSIS 1 0.0001
893 END STAGE RENAL DISEASE 1 0.0001
894 BLOOD GLUCOSE ABNORMAL 1 0.0001
895 HEPATIC STEATOSIS 1 0.0001
896 BLISTER 3 0.0001
897 OXYGEN SATURATION DECREASED 3 0.0001
898 BLOOD SODIUM DECREASED 1 0.0001
899 DYSPHAGIA 5 0.0001
900 GASTRIC ULCER 1 0.0001
901 BONE PAIN 3 0.0001
902 ABNORMAL BEHAVIOUR 2 0.0001
903 COUGH 14 0.0000
904 OEDEMA PERIPHERAL 6 0.0000
905 RENAL FAILURE ACUTE 2 0.0000
906 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
907 INFUSION RELATED REACTION 3 0.0000
908 ANGIOEDEMA 2 0.0000
909 SKIN DISCOLOURATION 2 0.0000
910 ADVERSE EVENT 4 0.0000
911 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
912 DECREASED APPETITE 10 0.0000
913 ABDOMINAL DISCOMFORT 7 0.0000
914 DRUG INTOLERANCE 4 0.0000
915 DYSPEPSIA 4 0.0000
916 WEIGHT INCREASED 9 0.0000
917 HYPOTENSION 8 0.0000
918 UNEVALUABLE EVENT 3 0.0000
919 DIABETES MELLITUS 3 0.0000
920 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
921 NO ADVERSE EVENT 7 0.0000
922 JOINT STIFFNESS 1 0.0000
923 RASH PRURITIC 2 0.0000
924 TREMOR 6 0.0000
925 MEDICATION ERROR 2 0.0000
926 INFLUENZA 4 0.0000
927 WEIGHT DECREASED 10 0.0000
928 DEMENTIA 1 0.0000
929 ALOPECIA 7 0.0000
930 EYE IRRITATION 2 0.0000
931 LIVER FUNCTION TEST ABNORMAL 1 0.0000
932 ERYTHEMA 7 0.0000
933 TACHYCARDIA 3 0.0000
934 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
935 PARAESTHESIA 5 0.0000
936 HYPOTHYROIDISM 1 0.0000
937 CHOLELITHIASIS 1 0.0000
938 EYE DISORDER 1 0.0000
939 BACK PAIN 7 0.0000
940 NEOPLASM MALIGNANT 2 0.0000
941 GASTRIC DISORDER 1 0.0000
942 VISION BLURRED 4 0.0000
943 DEATH 25 0.0000
944 ABDOMINAL DISTENSION 3 0.0000
945 HEADACHE 18 0.0000
946 BURNING SENSATION 2 0.0000
947 HEPATIC FUNCTION ABNORMAL 1 0.0000
948 ASTHENIA 10 0.0000
949 DYSARTHRIA 1 0.0000
950 DYSPNOEA EXERTIONAL 1 0.0000
951 INTESTINAL OBSTRUCTION 1 0.0000
952 BLINDNESS 1 0.0000
953 CARDIAC ARREST 2 0.0000
954 CARDIO-RESPIRATORY ARREST 1 0.0000
955 MUSCLE SPASMS 4 0.0000
956 CHEST PAIN 4 0.0000
957 HYPERSENSITIVITY 4 0.0000
958 ARRHYTHMIA 1 0.0000
959 NEUROPATHY PERIPHERAL 2 0.0000
960 PRURITUS 8 0.0000
961 SOMNOLENCE 4 0.0000
962 DERMATITIS ATOPIC 1 0.0000
963 CONSTIPATION 4 0.0000
964 ARTHROPATHY 1 0.0000
965 EYE PAIN 1 0.0000
966 FEELING HOT 1 0.0000
967 AGITATION 1 0.0000
968 PAIN IN EXTREMITY 4 0.0000
969 EPISTAXIS 1 0.0000
970 ARTHRITIS 1 0.0000
971 CARDIAC FAILURE CONGESTIVE 1 0.0000
972 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
973 COMPLETED SUICIDE 1 0.0000
974 MYALGIA 2 0.0000
975 BALANCE DISORDER 1 0.0000
976 DRUG WITHDRAWAL SYNDROME 1 0.0000
977 DYSPNOEA 6 0.0000
978 ANXIETY 3 0.0000
979 FATIGUE 8 0.0000
980 HEART RATE INCREASED 1 0.0000
981 ABDOMINAL PAIN UPPER 2 0.0000
982 ARTHRALGIA 4 0.0000
983 INSOMNIA 2 0.0000
984 DRY SKIN 1 0.0000
985 HYPOAESTHESIA 1 0.0000
986 HOSPITALISATION 1 0.0000
987 CEREBROVASCULAR ACCIDENT 1 0.0000
988 PAIN 3 0.0000
989 MALAISE 2 0.0000
990 DEPRESSION 1 0.0000
991 DIZZINESS 2 0.0000